{
    "Trade/Device Name(s)": [
        "APTIMA Trichomonas vaginalis Assay",
        "APTIMA Trichomonas vaginalis Assay (PANTHER System)"
    ],
    "Submitter Information": "Gen-Probe Incorporated",
    "510(k) Number": "K122062",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102911"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY"
    ],
    "Summary Letter Date": "December 27, 2012",
    "Summary Letter Received Date": "December 28, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "Trichomonas vaginalis Nucleic Acid Amplification Test System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Trichomonas vaginalis ribosomal RNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected endocervical swab",
        "Clinician-collected vaginal swab",
        "Specimen collected in PreservCyt Solution"
    ],
    "Specimen Container(s)": [
        "APTIMA Unisex Swab Specimen Collection Kit",
        "APTIMA Vaginal Swab Specimen Collection Kit",
        "APTIMA Specimen Transfer Kit"
    ],
    "Instrument(s)/Platform(s)": [
        "PANTHER System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification test (NAAT)",
        "Target Capture",
        "Transcription Mediated Amplification (TMA)",
        "Hybridization Protection Assay (HPA)"
    ],
    "Methodologies": [
        "Qualitative detection of ribosomal RNA using NAAT",
        "Target Capture",
        "TMA",
        "HPA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for APTIMA Trichomonas vaginalis Assay (Version 2) using NAAT for qualitative detection of Trichomonas vaginalis rRNA on PANTHER System.",
    "Indications for Use Summary": "Qualitative in vitro nucleic acid amplification test for detection of ribosomal RNA from Trichomonas vaginalis to aid in the diagnosis of trichomoniasis in symptomatic or asymptomatic women, using clinician-collected endocervical and vaginal swabs, and specimens collected in PreservCyt Solution on the PANTHER System.",
    "fda_folder": "Immunology"
}